Hamartoma

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Hamartoma
Classification and external resources
ICD-10 Q85.9
ICD-9 757.32, 759.6
DiseasesDB 19785
MeSH D006222

WikiDoc Resources for

Hamartoma

Articles

Most recent articles on Hamartoma

Most cited articles on Hamartoma

Review articles on Hamartoma

Articles on Hamartoma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hamartoma

Images of Hamartoma

Photos of Hamartoma

Podcasts & MP3s on Hamartoma

Videos on Hamartoma

Evidence Based Medicine

Cochrane Collaboration on Hamartoma

Bandolier on Hamartoma

TRIP on Hamartoma

Clinical Trials

Ongoing Trials on Hamartoma at Clinical Trials.gov

Trial results on Hamartoma

Clinical Trials on Hamartoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hamartoma

NICE Guidance on Hamartoma

NHS PRODIGY Guidance

FDA on Hamartoma

CDC on Hamartoma

Books

Books on Hamartoma

News

Hamartoma in the news

Be alerted to news on Hamartoma

News trends on Hamartoma

Commentary

Blogs on Hamartoma

Definitions

Definitions of Hamartoma

Patient Resources / Community

Patient resources on Hamartoma

Discussion groups on Hamartoma

Patient Handouts on Hamartoma

Directions to Hospitals Treating Hamartoma

Risk calculators and risk factors for Hamartoma

Healthcare Provider Resources

Symptoms of Hamartoma

Causes & Risk Factors for Hamartoma

Diagnostic studies for Hamartoma

Treatment of Hamartoma

Continuing Medical Education (CME)

CME Programs on Hamartoma

International

Hamartoma en Espanol

Hamartoma en Francais

Businness

Hamartoma in the Marketplace

Patents on Hamartoma

Experimental / Informatics

List of terms related to Hamartoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

A hamartoma is a focal malformation that resembles a neoplasm in the tissue of its origin. This is not a malignant tumor, and it grows at the same rate as the surrounding tissues. It is composed of tissue elements normally found at that site but that are growing in a disorganized mass. They occur in many different parts of the body and are most often asymptomatic and undetected unless seen on an image taken for another reason. Hamartomas result from an abnormal formation of normal tissue, although the underlying reasons for the abnormality are not fully understood. They grow along with, and at the same rate as, the organ from whose tissue they are made, and, unlike cancerous tumors, only rarely invade or compress surrounding structures significantly.

A hamartoma, while generally benign, can cause problems due to their location. When located on the skin, especially the face or neck, they can be extremely disfiguring, as in the case of a man with a hamartoma the size of a small orange on his eyelid.[1] They may obstruct practically any organ in the body, such as the eye, the colon, etc. They are particularly likely to cause major health issues when located in the hypothalamus, spleen or kidneys.

Lung

The most common hamartomas occur in the lungs. About 5-8% of all solitary lung tumors, about 75% of all benign lung tumors are hamartomas. They almost always arise from connective tissue and are generally formed of cartilage, fat, and connective tissue cells, although they may include many other types of cells. The great majority of them form in the connective tissue on the outside of the lungs, although about 10% form deep in the linings of the bronchii. They can be worrisome, especially if situated deep in the lung, as it is important and sometimes difficult to distinguish them from malignancies. An x-ray will often not provide definitive diagnosis, and even a CAT scan may be insufficient if the hamartoma atypically lacks cartilage and fat cells. Lung hamartomas are more common in men than in women and may present additional difficulties in smokers.

Some lung hamartomas can compress surrounding lung tissue to a degree, but this is generally not debilitative or even noticed by the patient, especially for the more common peripheral growths. They are treated, if at all, by surgical resection, with an excellent prognosis: generally, the only real danger is the inherent possibility of surgical complications.

Heart

Cardiac rhabdomyomas are hamartomas comprised of altered cardiac myocytes that contain large vacuoles and glycogen. They are the second most common tumor of the heart in children and infants (after fibromas). There is a strong association between cardiac rhabdomyomas and tuberous sclerosis (characterized by hamartomas of the central nervous system, kidneys and skin, as well as pancreatic cysts; 25-50% of patients with cardiac rhabdomyomas will have tuberous sclerosis, and up to 100% of patients with tuberous sclerosis will have cardiac masses by echocardiography. Symptoms depend on the size of the tumor, its location relative to the conduction system, and whether it obstructs blood flow. Symptoms are usually from congestive heart failure (in utero heart failure may occur). If patients survive infancy, their tumors may regress spontaneously; resection in symptomatic patients has good results.

Hypothalamus

One of the most troublesome hamartomas occurs on the hypothalamus. Unlike most such growths, a hypothalamic hamartoma is symptomatic; it most often causes gelastic seizures, and can cause visual problems, other seizures, rage disorders associated with hypothalamic diseases, and early onset of puberty. The symptoms typically begin in early infancy and are progressive, often into general cognitive and/or functional disability. Moreover, resection is usually difficult, as the growths are generally adjacent to, or even intertwined with, the optic nerve; however, the symptoms are resistant to medical control. Luckily, surgical techniques are improving and can result in immense improvement of prognosis. [1]

Kidneys, spleen, and other vascular organs

One general danger of hamartoma is that they may impinge into blood vessels, resulting in a risk of serious bleeding. Because hamartoma typically lacks elastic tissue, it may lead to the formation of aneurysms and thus possible hemorrhage. Where a hamartoma impinges into a major blood vessel, such as the renal artery, hemorrhage must be considered life-threatening.

Hamartoma of the kidney is also called angiomyolipoma and can be associated with tuberous sclerosis. It is one of the more frequently seen hamartomas. The condition is more prevalent in women than men, and generally occurs in the right kidney. Hamartomas of the spleen are uncommon, but can be dangerous. About 50% of such cases manifest abdominal pain and they are often associated with hematologic abnormalities and spontaneous rupture.


Angiomyolipoma is not a hamartoma by definition, because fat and smooth muscles are not normal constituents of renal parenchyma. It is a Choristoma (microscopically normal cells or tissues in abnormal locations).

Hamartoma of the spleen. The hamartoma is the dark circular object on the left that dominates the image. This is a cross-section, the growth being about 9 cm in diameter, while the spleen is actually about 11 cm. Courtesy of Ed Uthman, MD
Hamartoma of the spleen. The hamartoma is the dark circular object on the left that dominates the image. This is a cross-section, the growth being about 9 cm in diameter, while the spleen is actually about 11 cm. Courtesy of Ed Uthman, MD

Cowden syndrome

Cowden Syndrome or Cowden Disease is a serious genetic disorder [1] characterized by multiple hamartomas. Usually skin hamartomas exist, and commonly (about 66% of cases) hamartoma of the thyroid gland exists. Additional growths can form in many parts of the body, especially in mucosa, the GI tract, bones, CNS, the eyes, and the genourinary tract. The hamartomas themselves may cause symptoms or even death, but morbidity is more often associated with increased occurrence of malignancies, usually in the breast or thyroid.

Notes

External links


de:Hamartom

fr:Hamartome hu:Hamartoma ja:過誤腫

WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools
In other languages